{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:36Z","timestamp":1789056396964,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["MU 3861\/5-1"],"award-info":[{"award-number":["MU 3861\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201831","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:30:30Z","timestamp":1785886230000},"page":"201831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From epigenetic mark detection to rational design of epigenetic editing strategies"],"prefix":"10.1016","volume":"34","author":[{"given":"Ali","family":"Faiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibtain","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-1110","authenticated-orcid":false,"given":"Claudio","family":"Mussolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201831_bib1","series-title":"The Strategy of the Genes","author":"Waddington","year":"2014"},{"key":"10.1016\/j.omta.2026.201831_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omta.2026.201831_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.omta.2026.201831_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-biochem-052610-091920","article-title":"Programming of DNA methylation patterns","volume":"81","author":"Cedar","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omta.2026.201831_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1158\/1078-0432.CCR-06-2076","article-title":"DNA methylation as a therapeutic target in cancer","volume":"13","author":"Issa","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omta.2026.201831_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.omta.2026.201831_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-019-0376-8","article-title":"Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer","volume":"25","author":"Mohammad","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201831_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic therapeutics: a new weapon in the war against cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omta.2026.201831_bib11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: targeting epigenetic marks in cancer treatment","volume":"14","author":"Miranda Furtado","year":"2019","journal-title":"Epigenetics"},{"key":"10.1016\/j.omta.2026.201831_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2015.12.001","article-title":"Epigenome editing: state of the art, concepts, and perspectives","volume":"32","author":"Kungulovski","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.omta.2026.201831_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt.3853","article-title":"CRISPR\u2013Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome","volume":"35","author":"Klann","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nmeth.3325","article-title":"Functional annotation of native enhancers with a Cas9\u2013histone demethylase fusion","volume":"12","author":"Kearns","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib18","article-title":"Mechanisms and technologies in cancer epigenetics","volume":"14","author":"Sherif","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omta.2026.201831_bib19","article-title":"Cancer biomarkers discovery of methylation modification with direct high-throughput nanopore sequencing","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.omta.2026.201831_bib20","series-title":"Epigenetics Protocols","first-page":"11","article-title":"DNA methylation detection: bisulfite genomic sequencing analysis","author":"Li","year":"2011"},{"key":"10.1016\/j.omta.2026.201831_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1046-2023(02)00062-2","article-title":"Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives","volume":"27","author":"Rand","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.omta.2026.201831_bib22","series-title":"Chromatin Immunoprecipitation: Methods and Protocols","first-page":"29","article-title":"How to combine ChIP with qPCR","author":"Asp","year":"2017"},{"key":"10.1016\/j.omta.2026.201831_bib23","series-title":"Immunosenescence: Methods and Protocols","first-page":"249","article-title":"Analysis of DNA methylation by pyrosequencing","author":"Delaney","year":"2015"},{"key":"10.1016\/j.omta.2026.201831_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-016-0075-3","article-title":"Profiling genome-wide DNA methylation","volume":"9","author":"Yong","year":"2016","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.omta.2026.201831_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-8935-6-33","article-title":"Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing","volume":"6","author":"Masser","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.omta.2026.201831_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214368","article-title":"DNA methylation estimation using methylation-sensitive restriction enzyme bisulfite sequencing (MREBS)","volume":"14","author":"Bonora","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201831_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2144\/000112708","article-title":"Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome","volume":"44","author":"Jacinto","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.omta.2026.201831_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrg3980","article-title":"Single-cell epigenomics: techniques and emerging applications","volume":"16","author":"Schwartzman","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omta.2026.201831_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/genes10010062","article-title":"A high-quality de novo genome assembly from a single mosquito using PacBio sequencing","volume":"10","author":"Kingan","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.omta.2026.201831_bib30","first-page":"18904","volume":"110","author":"Laszlo","year":"2013"},{"key":"10.1016\/j.omta.2026.201831_bib31","series-title":"Leukemia: Methods and Protocols","first-page":"409","article-title":"Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins","author":"Milne","year":"2009"},{"key":"10.1016\/j.omta.2026.201831_bib32","series-title":"Epigenetics Protocols","first-page":"239","article-title":"Combined chromatin immunoprecipitation and bisulfite methylation sequencing analysis","author":"Li","year":"2011"},{"key":"10.1016\/j.omta.2026.201831_bib33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1101\/gr.132076.111","article-title":"Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA","volume":"22","author":"Statham","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.omta.2026.201831_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41592-019-0502-z","article-title":"Joint profiling of DNA methylation and chromatin architecture in single cells","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07107","article-title":"Genome-scale DNA methylation maps of pluripotent and differentiated cells","volume":"454","author":"Meissner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201831_bib36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201831_bib37","series-title":"5-hydroxymethylcytosine as a Liquid Biopsy Biomarker in Colorectal Cancer","author":"Maher","year":"2025"},{"key":"10.1016\/j.omta.2026.201831_bib38","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1021\/acs.analchem.4c06200","article-title":"Label-Free and Sequence-Independent Isothermal Amplification Strategy for the Simultaneous Detection of Genomic 5-Methylcytosine and 5-Hydroxymethylcytosine","volume":"97","author":"Zhang","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.omta.2026.201831_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/epigenomes9010004","article-title":"Single-molecule nanopore sequencing of the cpg island from the promoter of o6-methylguanine-dna methyltransferase provides insights into the mechanism of de novo methylation of g\/c-rich regions","volume":"9","author":"Sergeev","year":"2025","journal-title":"Epigenomes"},{"key":"10.1016\/j.omta.2026.201831_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf151","article-title":"Realfreq: real-time base modification analysis for nanopore sequencing","volume":"41","author":"Samarasinghe","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201831_bib41","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","article-title":"Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing","volume":"184","author":"Nu\u00f1ez","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12864-025-11266-w","article-title":"Insights from the single-cell level: lineage trajectory and somatic-germline interactions during spermatogenesis in dwarf surfclam Mulinia lateralis","volume":"26","author":"Li","year":"2025","journal-title":"BMC Genom."},{"key":"10.1016\/j.omta.2026.201831_bib43","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41467-021-22368-w","article-title":"Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney","volume":"12","author":"Muto","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/lifemedi\/lnae015","article-title":"Integration of single-cell transcriptome and chromatin accessibility and its application on tumor investigation","volume":"3","author":"Yang","year":"2024","journal-title":"Life Med."},{"key":"10.1016\/j.omta.2026.201831_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.niox.2019.08.005","article-title":"Sensitive and quantitative method to evaluate DNA methylation of the positive regulatory domains (PRDI, PRDII) and cAMP response element (CRE) in human endothelial nitric oxide synthase promoter","volume":"92","author":"Vigorelli","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.omta.2026.201831_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8827516","article-title":"Current advances in DNA methylation analysis methods","volume":"2021","author":"Khodadadi","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.omta.2026.201831_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.omta.2026.201831_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13072-017-0129-1","article-title":"Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells","volume":"10","author":"Okada","year":"2017","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.omta.2026.201831_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46314","article-title":"Improved CUT&RUN chromatin profiling tools","volume":"8","author":"Meers","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201831_bib50","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib51","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21856","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","volume":"6","author":"Skene","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201831_bib52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nmeth.3542","article-title":"ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors","volume":"12","author":"Schmidl","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-7896-0_22","article-title":"An Integrated and Semiautomated Microscaled Approach to Profile Cis-Regulatory Elements by Histone Modification ChIP-Seq for Large-Scale Epigenetic Studies. Type 2 Immunity","volume":"1799","author":"Youhanna Jankeel","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2026.201831_bib54","article-title":"A Semiautomated ChIP-Seq procedure for large-scale epigenetic studies","volume":"162","author":"Cayford","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omta.2026.201831_bib55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.csbj.2020.06.012","article-title":"Single-cell ATAC sequencing analysis: from data preprocessing to hypothesis generation","volume":"18","author":"Baek","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201831_bib56","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41576-025-00822-5","article-title":"Computational analysis of DNA methylation from long-read sequencing","volume":"26","author":"Fu","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omta.2026.201831_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13059-024-03207-9","article-title":"A comparison of methods for detecting DNA methylation from long-read sequencing of human genomes","volume":"25","author":"Sigurpalsdottir","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.omta.2026.201831_bib58","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/nar\/gkac123","article-title":"Determinants of heritable gene silencing for KRAB-dCas9+ DNMT3 and Ezh2-dCas9+ DNMT3 hit-and-run epigenome editing","volume":"50","author":"O\u2019Geen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201831_bib59","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12677","article-title":"Nucleosomes impede Cas9 access to DNA in vivo and in vitro","volume":"5","author":"Horlbeck","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201831_bib60","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.cell.2024.03.020","article-title":"Chromatin context-dependent regulation and epigenetic manipulation of prime editing","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omta.2026.201831_bib62","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1038\/s41598-023-32509-4","article-title":"DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors","volume":"13","author":"Laranjeira","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201831_bib63","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.34974","article-title":"Recent histone deacetylase inhibitors in cancer therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.omta.2026.201831_bib64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","article-title":"Tazemetostat: EZH2 inhibitor","volume":"13","author":"Straining","year":"2022","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.omta.2026.201831_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102148","article-title":"BET bromodomain inhibitors","volume":"68","author":"Schwalm","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.omta.2026.201831_bib66","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","article-title":"BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells","volume":"6","author":"Coud\u00e9","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omta.2026.201831_bib67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.omta.2026.201831_bib68","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41587-024-02320-1","article-title":"Epigenome editing technologies for discovery and medicine","volume":"42","author":"McCutcheon","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib69","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201831_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj4008","article-title":"CRISPR activation and interference screens decode stimulation responses in primary human T cells","volume":"375","author":"Schmidt","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201831_bib72","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41592-023-02036-1","article-title":"Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control","volume":"20","author":"Mahata","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/cr.2016.3","article-title":"Casilio: a versatile CRISPR-Cas9-Pumilio hybrid for gene regulation and genomic labeling","volume":"26","author":"Cheng","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.omta.2026.201831_bib74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41587-019-0296-7","article-title":"Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery","volume":"38","author":"Chiarella","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15993","article-title":"Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping","volume":"8","author":"Morgan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib76","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","article-title":"A protein-tagging system for signal amplification in gene expression and fluorescence imaging","volume":"159","author":"Tanenbaum","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib77","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1080\/15592294.2022.2106646","article-title":"Precise epigenomic editing with a SunTag-based modular epigenetic toolkit","volume":"17","author":"Guhathakurta","year":"2022","journal-title":"Epigenetics"},{"key":"10.1016\/j.omta.2026.201831_bib78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nmeth.3433","article-title":"Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display","volume":"12","author":"Shechner","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib79","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41467-017-00644-y","article-title":"Rapid and reversible epigenome editing by endogenous chromatin regulators","volume":"8","author":"Braun","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib80","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1093\/nar\/gky171","article-title":"Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells","volume":"46","author":"Mlambo","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201831_bib81","article-title":"Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing","volume":"36","author":"Azcona","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2026.201831_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/science.ado7082","article-title":"Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor","volume":"384","author":"Neumann","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201831_bib83","article-title":"Rational design of a compact CRISPR-Cas9 activator for AAV-mediated delivery","author":"Vora","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.omta.2026.201831_bib84","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1038\/s41467-025-63167-x","article-title":"Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41592-021-01207-2","article-title":"Transgenic mice for in vivo epigenome editing with CRISPR-based systems","volume":"18","author":"Gemberling","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib86","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9\u2013based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib87","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","article-title":"An enhanced CRISPR repressor for targeted mammalian gene regulation","volume":"15","author":"Yeo","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-019-0275-8","article-title":"Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner","volume":"12","author":"O\u2019Geen","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.omta.2026.201831_bib89","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","article-title":"LSD1: more than demethylation of histone lysine residues","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omta.2026.201831_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15315","article-title":"Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC","volume":"8","author":"Kwon","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16026","article-title":"Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein","volume":"8","author":"Lei","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib92","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1038\/s41598-017-06757-0","article-title":"Targeted DNA methylation in human cells using engineered dCas9-methyltransferases","volume":"7","author":"Xiong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201831_bib93","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib94","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.stem.2016.07.001","article-title":"Targeted epigenetic remodeling of endogenous loci by CRISPR\/Cas9-based transcriptional activators directly converts fibroblasts to neuronal cells","volume":"19","author":"Black","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201831_bib95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nmeth.3312","article-title":"Highly efficient Cas9-mediated transcriptional programming","volume":"12","author":"Chavez","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201831_bib96","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1073\/pnas.1707635114","article-title":"Optimized strategy for in vivo Cas9-activation in Drosophila","volume":"114","author":"Ewen-Campen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201831_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104954","article-title":"CRISPR\/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice","volume":"141","author":"Yamagata","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2026.201831_bib98","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201831_bib99","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/s41467-018-05766-5","article-title":"High-fidelity CRISPR\/Cas9-based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib100","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/nar\/gkac344","article-title":"Epigenome editing reveals core DNA methylation for imprinting control in the Dlk1-Dio3 imprinted domain","volume":"50","author":"Kojima","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201831_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12284","article-title":"Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner","volume":"7","author":"Cano-Rodriguez","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib102","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1093\/nar\/gkv874","article-title":"Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells","volume":"43","author":"Kim","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201831_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65986-4","article-title":"Combinatorial protein engineering identifies potent CRISPR activators with reduced toxicity","volume":"16","author":"Giddins","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib104","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.omtm.2021.04.009","article-title":"Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing","volume":"21","author":"Alves","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201831_bib105","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acssynbio.1c00606","article-title":"Bioorthogonal chemical epigenetic modifiers enable dose-dependent CRISPR targeted gene activation in mammalian cells","volume":"11","author":"Lu","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.omta.2026.201831_bib106","series-title":"Epigenome Editing: Methods and Protocols","first-page":"179","article-title":"Protocol for Allele-Specific Epigenome Editing Using CRISPR\/dCas9","author":"Rajaram","year":"2024"},{"key":"10.1016\/j.omta.2026.201831_bib107","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1039\/C7CS00822H","article-title":"Coiled coil protein origami: from modular design principles towards biotechnological applications","volume":"47","author":"Lapenta","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.omta.2026.201831_bib108","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41589-019-0443-y","article-title":"A tunable orthogonal coiled-coil interaction toolbox for engineering mammalian cells","volume":"16","author":"Lebar","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omta.2026.201831_bib109","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92991","article-title":"Predicting the effect of CRISPR-Cas9-based epigenome editing","volume":"12","author":"Batra","year":"2026","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201831_bib110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nbt.4061","article-title":"Deep learning improves prediction of CRISPR\u2013Cpf1 guide RNA activity","volume":"36","author":"Kim","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201831_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae481","article-title":"DeepCRISTL: deep transfer learning to predict CRISPR\/Cas9 on-target editing efficiency in specific cellular contexts","volume":"40","author":"Elkayam","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201831_bib112","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/ncomms2562","article-title":"UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9","volume":"4","author":"Liu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib113","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41422-020-0359-9","article-title":"Kinetics and mechanisms of mitotic inheritance of DNA methylation and their roles in aging-associated methylome deterioration","volume":"30","author":"Ming","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.omta.2026.201831_bib114","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1073\/pnas.2009316117","article-title":"Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation","volume":"117","author":"Ren","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201831_bib115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/35065132","article-title":"Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins","volume":"410","author":"Lachner","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201831_bib116","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.trecan.2025.08.010","article-title":"Viral mimicry in cancer therapy","volume":"11","author":"Rosenberg","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omta.2026.201831_bib117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omta.2026.201831_bib118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13148-026-02085-1","article-title":"Epigenetic editing to advance CAR T cell therapy","volume":"18","author":"Horvathova","year":"2026","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.omta.2026.201831_bib119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-025-01856-6","article-title":"Epigenetic regulators combined with tumour immunotherapy: current status and perspectives","volume":"17","author":"Zhang","year":"2025","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.omta.2026.201831_bib120","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ymthe.2023.01.013","article-title":"Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model","volume":"31","author":"O\u2019Geen","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201831_bib121","article-title":"Activation of the imprinted Prader-Willi syndrome locus by CRISPR-based epigenome editing","volume":"5","author":"Rohm","year":"2025","journal-title":"Cell Genom."},{"key":"10.1016\/j.omta.2026.201831_bib122","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3390\/ijms26094067","article-title":"Fine-Tuning Homology-Directed Repair (HDR) for Precision Genome Editing: Current Strategies and Future Directions","volume":"26","author":"Haider","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201831_bib123","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/genes14030577","article-title":"Epigenetic regulation of \u03b2-globin genes and the potential to treat hemoglobinopathies through epigenome editing","volume":"14","author":"Fontana","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.omta.2026.201831_bib124","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1038\/s41467-025-62177-z","article-title":"Removal of promoter CpG methylation by epigenome editing reverses HBG silencing","volume":"16","author":"Bell","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201831_bib125","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf637","article-title":"Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for \u03b2-hemoglobinopathies","volume":"53","author":"Amistadi","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201831_bib126","author":"Trials"},{"key":"10.1016\/j.omta.2026.201831_bib127","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0168-8278(24)00534-8","article-title":"OS-093 Efficient and heritable elimination of HBV viral antigens in vivo by epigenome editing","volume":"80","author":"Peng","year":"2024","journal-title":"J. Hepatol."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:11Z","timestamp":1789053131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001667"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201831","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From epigenetic mark detection to rational design of epigenetic editing strategies","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201831"}}